IL2 and colitis: Therefore, tissue‐prevalent mast cells stimulated by a combination of IL‐3 and IL‐33 would secrete high levels of IL‐6, but not IL‐2, and represent potential mediators of the negative regulatory role of IL‐3 in colitis‐mediated immune responses by induction of RORγt+ Tregs.48